Marshall Wace’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$39.3M Buy
900,300
+899,400
+99,933% +$41.6M 0.03% 420
2026
Q2
$38.4K Buy
900
+700
+350% +$38K ﹤0.01% 3006
2026
Q1
$12.6K Sell
200
-499,800
-100% -$40M ﹤0.01% 3083
2025
Q4
$47.7M Buy
+500,000
New +$49M 0.04% 354

Other funds holding BSX

Marshall Wace's BSX Position: Q3 2026 in Review

Marshall Wace reduced its Boston Scientific (BSX) stake by 46% in Q3 2026, selling an estimated $51.4M and leaving 1,303,153 shares worth $56.9M. The position accounts for 0.05% of the portfolio, ranked #304.

Marshall Wace first reported a position in BSX in Q3 2014 and has held it in 48 quarters since. The position peaked at $957M in Q3 2025. 1,515 funds tracked by Wall St. Rank hold BSX as of Q3 2026.

  • Marshall Wace held 1,303,153 shares of Boston Scientific worth $56.9M as of Q3 2026.
  • Marshall Wace sold 1,111,070 Boston Scientific shares in Q3 2026, an estimated $51.4M.
  • Boston Scientific made up 0.05% of Marshall Wace's portfolio in Q3 2026, its #304 holding.
  • Marshall Wace first reported a position in Boston Scientific in Q3 2014 and has held it in 48 quarters since.
  • Marshall Wace's Boston Scientific position peaked at $957M in Q3 2025.
  • 1,515 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2026.

Based on Marshall Wace's 13F filing for Q3 2026, filed 13 Nov 2026.